Clinical Trial Update: Azole-echinocandin Combination Therapy for Invasive Aspergillosis [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating azole-echinocandin combination therapy for invasive aspergillosis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Aspergillosis

Drugs mentioned

• Azole-echinocandin combination therapy

Snippet

Sponsor: Erasmus Medical Center | Conditions: Invasive Aspergillosis | Phase 3 | Status: TERMINATED